FDA
approval
· 2023-06-26
FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
Summary
FDA approved a supplemental application for buprenorphine and naloxone by Rhodes Pharmaceuticals L.P., supporting the continued use of this combination for the …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)